Allopurinol

Therapeutic Classification

Allopurinol is classified as a xanthine oxidase inhibitor. It is primarily used to reduce the production of uric acid in the body.

Indications for Use

Allopurinol is indicated for the management of primary and secondary gout. It is also used for preventing uric acid nephropathy during chemotherapy. Additionally, it is used in the treatment of recurrent calcium oxalate stones.

Dosage Forms Available

Allopurinol is available in oral tablets. Commonly prescribed dosage strengths include 100 mg and 300 mg tablets.

Mechanism of Action

Allopurinol works by inhibiting the activity of xanthine oxidase, an enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid. This results in decreased production of uric acid.

Starting Dosage Recommendation

For adults, the typical starting dosage of Allopurinol for the treatment of gout is 100 mg once daily. Dosage may be titrated based on patient response and tolerability.

Maintenance Dosage

The maintenance dosage may range from 100 mg to 800 mg daily, often divided into two or three doses. Elderly patients may require lower dosages due to reduced renal function.

Administering the Medication

Allopurinol tablets should be taken orally, preferably after meals to minimize gastrointestinal discomfort. Patients requiring high dosages may benefit from a divided dosage schedule. Adequate hydration is advisable to prevent kidney stone formation.

Drug Interactions

Allopurinol may interact with certain medications including azathioprine and mercaptopurine, potentially necessitating dosage adjustments. Increased risk of rash may occur when combined with ampicillin or amoxicillin.

Special Populations Consideration

Renal impairment necessitates dosage reduction to prevent accumulation and toxicity. Patients with liver impairment should be monitored closely. The risk-benefit ratio should be evaluated in pregnant or breastfeeding women.

Side Effects Profile

Common side effects of Allopurinol include skin rash, gastrointestinal upset, and drowsiness. Severe reactions, although rare, can include Stevens-Johnson syndrome and liver enzyme abnormalities.

Monitoring Recommendations

Regular monitoring of serum uric acid levels is recommended to assess the efficacy of Allopurinol. Renal function tests should be conducted periodically, particularly in patients with pre-existing renal conditions.

Overdose Management

In the event of an Allopurinol overdose, supportive measures including gastric lavage may be considered. Activated charcoal may be administered to limit systemic absorption. Symptomatic treatment should be provided.

Prescriber’s Considerations

Allopurinol therapy should be initiated after an acute gout attack has resolved to prevent exacerbation. Gradual dose escalation helps minimize the risk of hypersensitivity reactions. Patient compliance and education regarding the importance of adherence are crucial.

Storage Information

Store Allopurinol tablets at room temperature, away from moisture and direct light. Ensure that the medication is kept out of reach of children to prevent accidental ingestion.

Patient Counseling Points

Patients should be informed about the potential side effects and the importance of reporting any signs of hypersensitivity. They should also be advised on dietary modifications to assist in the management of hyperuricemia.